Home Mechanical Ventilation in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Hypercapnic Response
NCT ID: NCT01120574
Last Updated: 2017-03-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2005-10-31
2015-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
We will include clinically stable COPD patients with hypercapnic CRF who develop a nocturnal hypercapnic response to oxygen (PaCO2 increase on awakening, at night with oxygen, \>10 mmHg respect to PaCO2 breathing room air and awake). Obstructive sleep apnoea syndrome (OSAS) will previously have been excluded.
Patients will be admitted to the Pneumology ward where a nocturnal pulsioxymetry breathing oxygen therapy will be performed. Arterial blood gas samples will be taken at awakening (7AM).
Patients who develop a hypercapnic response to oxygen will be randomised into 2 treatment groups:
* Oxygen therapy group
* Home mechanical ventilation plus oxygen therapy group Home mechanical ventilation will be performed with a bilevel pressure ventilator. Functional respiratory variables as well as quality of life and sleep at onset and after 6 months treatment will be compared.
The principal outcome will be the evolution of arterial blood gases (PaCO2) between the two groups.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effects of Nocturnal Non-invasive Ventilation in Stable COPD
NCT03053973
Effect of Extracorporeal CO2 Removal in Stable Hypercapnic COPD Patients
NCT02260583
Initiation of Home Mechanical Ventilation at Home in Patients With Chronic Hypercapnic Respiratory Failure
NCT03203577
Home Non-invasive Ventilation for Chronic Obstructive Pulmonary Disease Patients
NCT01526642
Home Non Invasive Ventilation for COPD Patients
NCT03221101
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Oxygen therapy group.
No interventions assigned to this group
2
Home mechanical ventilation plus oxygen therapy group.
Home mechanical ventilation
Home mechanical ventilation will be performed with a bilevel pressure ventilator.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Home mechanical ventilation
Home mechanical ventilation will be performed with a bilevel pressure ventilator.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* COPD (ERS/ATS (FEV1 \< 80%, FEV1/FVC \< 70%, TLC \> 80%)).
* Oxygen therapy indication (PaO2 \< 55 mmHg or 55-59 associated to pulmonary arterial hypertension, chronic Cor Pulmonale, Chronic Heart failure, arrhythmias or polyglobulia).
* PaCO2 \> 50 mm Hg.
* Clinically stable at least prior to one month.
* Hypercapnic response: increasing PaCO2 \> 10 mmHg at 7 a.m after all night with oxygen compared with PaCO2 when awake and without oxygen therapy.
Exclusion Criteria
* Bronchiectasis or tuberculous after-effects.
* Chronic respiratory failure secondary to thorax cage or neuromuscular diseases.
* BMI \> 35 kg/m2
* OSAS.
* Locomotor system problems that disable 6 minutes walking test execution.
* Patients with tracheostomy.
* Other serious comorbidity (i.e chronic heart failure functional class \> II NYHA, cancer or chronic renal failure that requires dialysis.
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fundació Institu de Recerca de l'Hospital de la Santa Creu i Sant Pau
Barcelona, Barcelona, Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PR05/05/2007
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.